These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 1681331)
1. Pharmacotoxic psychosis after memantine in Parkinson's disease. Riederer P; Lange KW; Kornhuber J; Danielczyk W Lancet; 1991 Oct; 338(8773):1022-3. PubMed ID: 1681331 [No Abstract] [Full Text] [Related]
2. [Acute pharmacotoxic psychoses in patients with chronic cerebral disorders]. Danielczyk W Wien Med Wochenschr Suppl; 1979; 55():1-15. PubMed ID: 34935 [TBL] [Abstract][Full Text] [Related]
3. Clozapine treatment of psychosis in patients with Parkinson's disease. Friedman JH J Clin Psychiatry; 1994 Feb; 55(2):79. PubMed ID: 8077160 [No Abstract] [Full Text] [Related]
5. Transderm-induced psychosis in Parkinson's disease. Quinn N Neurology; 2000 May; 54(9):1877. PubMed ID: 10802809 [No Abstract] [Full Text] [Related]
6. Ziprasidone in Parkinson's disease psychosis. Connemann BJ; Schönfeldt-Lecuona C Can J Psychiatry; 2004 Jan; 49(1):73. PubMed ID: 14763682 [No Abstract] [Full Text] [Related]
7. [Treatment of pharmacotoxic psychoses with clopenthixol in patients with Parkinson's disease (author's transl)]. Danielczyk W Wien Klin Wochenschr; 1981 Aug; 93(15):500-1. PubMed ID: 7303692 [TBL] [Abstract][Full Text] [Related]
13. Psychotic symptoms resulting from intraventricular infusion of dopamine in Parkinson's disease. Kulkarni J; Horne M; Butler E; Keks N; Copolov D Biol Psychiatry; 1992 Jun; 31(12):1225-7. PubMed ID: 1391283 [No Abstract] [Full Text] [Related]
14. Clozapine therapeutic plunge in patient with Parkinson's disease. Greene P Lancet; 1995 May; 345(8958):1172-3. PubMed ID: 7723559 [No Abstract] [Full Text] [Related]
15. Delusional psychosis induced by dopamine agonists in the treatment of Parkinson’s disease: four clinical cases. Bertolín JM; Sáez R; Morant Y Actas Esp Psiquiatr; 2017 Mar; 45(2):79-88. PubMed ID: 28353294 [No Abstract] [Full Text] [Related]
16. Use of lisuride in advanced Parkinson's disease. Potent dopamine and serotonin agonist. Lieberman AN; Goldstein M; Neophytides A; Leibowitz M; Gopinathan G; Goodgold A; Pact V; Walker R N Y State J Med; 1981 Nov; 81(12):1751-5. PubMed ID: 6949052 [No Abstract] [Full Text] [Related]
17. Ziprasidone for drug-induced psychotic symptoms in Parkinson's Disease. Duggal HS; Singh I Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):583-4. PubMed ID: 18022304 [No Abstract] [Full Text] [Related]
18. Clozapine in the treatment of psychosis in Parkinson's disease. Friedman JH; Lannon MC Neurology; 1989 Sep; 39(9):1219-21. PubMed ID: 2771073 [TBL] [Abstract][Full Text] [Related]
19. [Preliminary report on the action of cyclobenzaprine (MK-130) in Parkinson's disease]. Molina-Negro P; Illingworth RA Union Med Can; 1973 Feb; 102(2):303-8. PubMed ID: 4709461 [No Abstract] [Full Text] [Related]
20. [Psychosis due to the interaction of erythromycin and bromocriptine in Parkinson disease]. Alegre M; Noé E; Martínez Lage JM Neurologia; 1997 Nov; 12(9):429. PubMed ID: 9471184 [No Abstract] [Full Text] [Related] [Next] [New Search]